FAMICORD AG (V3V.DE) Stock Fundamental Analysis
FRA:V3V - Deutsche Boerse Ag - DE000A0BL849 - Common Stock - Currency: EUR
Overall V3V gets a fundamental rating of 3 out of 10. We evaluated V3V against 27 industry peers in the Health Care Providers & Services industry. V3V may be in some trouble as it scores bad on both profitability and health. V3V has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
V3V had positive earnings in the past year.
V3V had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: V3V reported negative net income in multiple years.
Of the past 5 years V3V 4 years had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.61%, V3V is in line with its industry, outperforming 51.85% of the companies in the same industry.
V3V's Return On Equity of 10.63% is fine compared to the rest of the industry. V3V outperforms 70.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.61% | ||
| ROE | 10.63% | ||
| ROIC | N/A |
ROA(3y)-7.04%
ROA(5y)-3.48%
ROE(3y)-60.2%
ROE(5y)-34.49%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
V3V has a Profit Margin of 3.20%. This is in the better half of the industry: V3V outperforms 66.67% of its industry peers.
V3V has a Gross Margin (36.66%) which is in line with its industry peers.
In the last couple of years the Gross Margin of V3V has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 3.2% | ||
| GM | 36.66% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.67%
GM growth 5Y-8.9%
2. Health
2.1 Basic Checks
V3V does not have a ROIC to compare to the WACC, probably because it is not profitable.
V3V has more shares outstanding than it did 1 year ago.
The number of shares outstanding for V3V has been increased compared to 5 years ago.
V3V has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.45, we must say that V3V is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.45, V3V is doing worse than 77.78% of the companies in the same industry.
The Debt to FCF ratio of V3V is 2.09, which is a good value as it means it would take V3V, 2.09 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of V3V (2.09) is better than 96.30% of its industry peers.
V3V has a Debt/Equity ratio of 0.56. This is a neutral value indicating V3V is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.56, V3V is doing good in the industry, outperforming 77.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | 2.09 | ||
| Altman-Z | 0.45 |
ROIC/WACCN/A
WACC6.02%
2.3 Liquidity
A Current Ratio of 0.76 indicates that V3V may have some problems paying its short term obligations.
V3V has a worse Current ratio (0.76) than 70.37% of its industry peers.
V3V has a Quick Ratio of 0.76. This is a bad value and indicates that V3V is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.70, V3V perfoms like the industry average, outperforming 40.74% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.76 | ||
| Quick Ratio | 0.7 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 109.51% over the past year.
Looking at the last year, V3V shows a small growth in Revenue. The Revenue has grown by 7.73% in the last year.
The Revenue has been growing by 30.44% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)109.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%160%
Revenue 1Y (TTM)7.73%
Revenue growth 3Y57.65%
Revenue growth 5Y30.44%
Sales Q2Q%8.91%
3.2 Future
The Earnings Per Share is expected to grow by 32.64% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 2.88% on average over the next years.
EPS Next Y58.33%
EPS Next 2Y35.4%
EPS Next 3Y32.64%
EPS Next 5YN/A
Revenue Next Year9.33%
Revenue Next 2Y7.77%
Revenue Next 3Y6.85%
Revenue Next 5Y2.88%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 29.43, which means the current valuation is very expensive for V3V.
V3V's Price/Earnings ratio is a bit more expensive when compared to the industry. V3V is more expensive than 62.96% of the companies in the same industry.
V3V's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.25.
V3V is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.43 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of V3V indicates a somewhat cheap valuation: V3V is cheaper than 62.96% of the companies listed in the same industry.
70.37% of the companies in the same industry are more expensive than V3V, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.1 | ||
| EV/EBITDA | 8.59 |
4.3 Compensation for Growth
V3V's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as V3V's earnings are expected to grow with 32.64% in the coming years.
PEG (NY)0.5
PEG (5Y)N/A
EPS Next 2Y35.4%
EPS Next 3Y32.64%
5. Dividend
5.1 Amount
No dividends for V3V!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:V3V (5/30/2025, 7:00:00 PM)
4.12
+0.12 (+3%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners2.65%
Inst Owner ChangeN/A
Ins Owners58.45%
Ins Owner ChangeN/A
Market Cap72.68M
Analysts84
Price Target6.43 (56.07%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.43 | ||
| Fwd PE | N/A | ||
| P/S | 0.9 | ||
| P/FCF | 8.1 | ||
| P/OCF | 6 | ||
| P/B | 2.99 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.59 |
EPS(TTM)0.14
EY3.4%
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)0.51
FCFY12.35%
OCF(TTM)0.69
OCFY16.66%
SpS4.57
BVpS1.38
TBVpS-1.68
PEG (NY)0.5
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.61% | ||
| ROE | 10.63% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 3.2% | ||
| GM | 36.66% | ||
| FCFM | 11.13% |
ROA(3y)-7.04%
ROA(5y)-3.48%
ROE(3y)-60.2%
ROE(5y)-34.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.67%
GM growth 5Y-8.9%
F-Score7
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | 2.09 | ||
| Debt/EBITDA | 1.65 | ||
| Cap/Depr | 35.61% | ||
| Cap/Sales | 3.89% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 147.25% | ||
| Profit Quality | 347.6% | ||
| Current Ratio | 0.76 | ||
| Quick Ratio | 0.7 | ||
| Altman-Z | 0.45 |
F-Score7
WACC6.02%
ROIC/WACCN/A
Cap/Depr(3y)60.39%
Cap/Depr(5y)47.49%
Cap/Sales(3y)7.53%
Cap/Sales(5y)6.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)109.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%160%
EPS Next Y58.33%
EPS Next 2Y35.4%
EPS Next 3Y32.64%
EPS Next 5YN/A
Revenue 1Y (TTM)7.73%
Revenue growth 3Y57.65%
Revenue growth 5Y30.44%
Sales Q2Q%8.91%
Revenue Next Year9.33%
Revenue Next 2Y7.77%
Revenue Next 3Y6.85%
Revenue Next 5Y2.88%
EBIT growth 1Y97.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year562.86%
EBIT Next 3Y100.95%
EBIT Next 5Y74.16%
FCF growth 1Y198.46%
FCF growth 3Y20.6%
FCF growth 5Y6%
OCF growth 1Y520.19%
OCF growth 3Y37.37%
OCF growth 5Y14.78%